2020
DOI: 10.1016/j.radonc.2020.09.054
|View full text |Cite
|
Sign up to set email alerts
|

From multisource data to clinical decision aids in radiation oncology: The need for a clinical data science community

Abstract: Big data are no longer an obstacle; now, by using artificial intelligence (AI), previously undiscovered knowledge can be found in massive data collections. The radiation oncology clinic daily produces a large amount of multisource data and metadata during its routine clinical and research activities. These data involve multiple stakeholders and users. Because of a lack of interoperability, most of these data remain unused, and powerful insights that could improve patient care are lost. Changing the paradigm by… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
21
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
3
1

Relationship

3
7

Authors

Journals

citations
Cited by 26 publications
(21 citation statements)
references
References 74 publications
0
21
0
Order By: Relevance
“…Incorporating powerful AI algorithms has been instrumental in changing the presentation and common sense of high-intensity radiation oncology. However, this is possible by establishing a clinical scientific community with radiation oncology [46]. 4 Computational and Mathematical Methods in Medicine 3.2.…”
Section: Applications Of Big Data and Aimentioning
confidence: 99%
“…Incorporating powerful AI algorithms has been instrumental in changing the presentation and common sense of high-intensity radiation oncology. However, this is possible by establishing a clinical scientific community with radiation oncology [46]. 4 Computational and Mathematical Methods in Medicine 3.2.…”
Section: Applications Of Big Data and Aimentioning
confidence: 99%
“…CT images in particular might not accurately reflect the biological tumour characteristics due to insu cient resolution, sensitivity to acquisition parameters and noise 48,49 , as well as the source of image contrast, which is essentially electron density of the tissue which demonstrates little texture at current image scales. This highlights the broader need of greater collaboration between ML researchers, clinicians and physicists, also in data selection and experiment design -with reciprocal feedback 50,51 .…”
Section: Discussionmentioning
confidence: 99%
“…Despite all this activity and despite that some ML tools (such as linear regression or atlas‐based segmentation) have been available and used for some time, AI is still in its early days of clinical application in MI and RO, and there are a range of issues and challenges still to be considered and solved 3,4,6,9,12,14,17 . These include potential hazards and risks in clinical use, which require: clear and safe development of AI tools and applications and a responsibility on developers and researchers to provide sufficient detail in documentation and in research papers; rigorous validation and testing of both accuracy and limitations; risk assessment and management of clinical implementation; on‐going quality assurance; and appropriate evolving education and training.…”
Section: Challenges and Requirementsmentioning
confidence: 99%